The association between male infertility and cardiometabolic disturbances : A population-based study by Behboudi-Gandevani, Samira et al.
Int J Endocrinol Metab. 2021 April; 19(2):e107418.
Published online 2021 April 13.
doi: 10.5812/ijem.107418.
Research Article
The Association Between Male Infertility and Cardiometabolic
Disturbances: A Population-Based Study
Samira Behboudi-Gandevani 1, Razieh Bidhendi Yarandi 2, Marzieh Rostami Dovom 2, Fereidoun
Azizi 3 and Fahimeh Ramezani Tehrani 2, *
1Faculty of Nursing and Health Sciences, Nord University, Bodø, Norway
2Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3Endocrin Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
*Corresponding author: Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Email: ramezani@endocrine.ac.ir
Received 2020 July 27; Revised 2021 January 13; Accepted 2021 February 17.
Abstract
Background: Further studies are needed to extend our knowledge about the association between male infertility and cardio-
metabolic disorders.
Objectives: We aimed to assess the association between male infertility and cardiometabolic disturbances using a population-based
design.
Methods: In total, 1611 participants of the Tehran-Lipid and Glucose-Study (phase III) were categorized into two groups of men with
documented male infertility (n = 88) and those with at least one live birth and no history of primary infertility (n = 1523). Logistic
regression was applied to explore the association between male infertility and cardiometabolic disturbances, including diabetes
mellitus, pre-diabetes, hypertension, metabolic syndrome, dyslipidemia, obesity, central obesity, and chronic kidney disease, fol-
lowing adjustment for age and body mass index (BMI).
Results: The unadjusted model revealed a significant association between infertility and hypertension and CKD (OR = 1.8; 95% CI: 1.2,
2.9, P-value = 0.006 and OR = 1.9; 95% CI: 1.1, 3.6, P-value = 0.033), respectively. However, after adjusting for age and BMI, as potential
confounders, this association was not significant. Moreover, there was no association between infertility and other cardiometabolic
disturbances, including diabetes and pre-diabetes, metabolic syndrome, dyslipidemia, obesity, and central obesity in both unad-
justed and adjusted models.
Conclusions: Our study revealed no association between male infertility and cardiometabolic disturbances. The findings can pave
the way for further studies to extend our knowledge in this field. More population-based studies with a large sample size are war-
ranted to confirm these findings.
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1. Background
Male-factor infertility, as one of the most common
causes of infertility, is solely responsible for 10 - 30% of in-
fertility cases and contributes to 50% of all infertile cases
overall (1-4). Male infertility is a major public health con-
cern with severe negative psychological burden, health
costs, ostracism, and social discrimination in some con-
texts with a strong emphasis on childbearing.
While there has been extensive focus on female infer-
tility, according to the literature, there is a correlation be-
tween some chronic disorders and male infertility, varying
from cardiometabolic, autoimmune, and oncologic disor-
ders to increased mortality rate later in life (5-9). The exact
underlying pathophysiology of these associations remains
unclear, although it is suggested that genetic, intrauterine
environment and lifestyle factors may play a role (8, 10-12).
However, not only a few studies have focused on the
association between male infertility and cardio-metabolic
disorders, but also their findings are controversial. More-
over, most of those studies had some important limita-
tions, including using the surrogate markers of infertil-
ity such as varicocele or childless situation of men or fol-
lowing a non-population based design, which may not re-
flect the characteristics of the target population, lack of ap-
propriate adjustments for potential confounders like age
and BMI, which limited the generalizability of their find-
ings. In this respect, Eisenberg et al. (2011) evaluated the
association between fatherhood and the risk of cardiovas-
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cular death in a population of US males average of 10.2
years. They reported that men with no child were at in-
creased risk of cardiovascular mortality after the age of 50
compared to those with two or more children (13). How-
ever, as being childless is not equivalent to infertility, cau-
tion should be taken when interpreting the results of this
study. In another epidemiological study, Wang et al. re-
ported that men who were suffering from varicoceles had
an increased risk of developing cardiovascular problems,
diabetes, and hyperlipidemia compared to men with va-
sectomy (14). Another retrospective cohort study, which
used national databases, reported that male infertility was
associated with a higher risk of developing diabetes and is-
chemic heart disease in the years after an infertility eval-
uation compared to men receiving only fertility testing
(15). However, although varicoceles may be associated with
male infertility, suffering from this disorder does not nec-
essarily specify male infertility; thus, limiting the inter-
pretability of the findings.
2. Objectives
Regarding the inaccessibility of necessary data, follow-
ing a population-based design, the current study aimed
to assess the association between male infertility and
cardiometabolic disturbances among participants of the
Tehran lipid and glucose study.
3. Methods
The current study’s participants were chosen from the
Tehran Lipid and Glucose Study (TLGS). The TLGS is a long-
term, the population-based study started in 1998 intended
to assess the non-communicable disease risk in a repre-
sentative population of men and women living in Tehran,
Iran; a total of 15005, who were older than 3 years, have
been monitored in intervals of 3 years, and all of their
related characteristics, examinations, and measured data
have been recorded. Comprehensive details of the TLGS are
published previously (16, 17).
Research Institute for Endocrine Sciences ethics com-
mittee has approved the study protocol. In addition, writ-
ten informed consent was obtained from all participants.
3.1. Study Population
For the purpose of the present study, we used data col-
lected in the third follow-up visit of TLGS, which included
comprehensive data on the reproductive status of partici-
pants (16). All those who were never married, were unwill-
ing to have a child or had documented female infertility
were excluded from the study. Eventually, in total, 1611 eli-
gible individuals were categorized into two groups of men
with documented male infertility (n = 88) and those with
at least one live birth and no history of primary infertility
(n = 1523).
3.2. Measurements
All clinical, anthropometric, and biochemical parame-
ters were measured by trained staffs. Comprehensive de-
tails for the TLGS measurement are published elsewhere
(18, 19). In brief, blood samples were taken after 12 h
of overnight fasting. Triglyceride (TG) levels were mea-
sured using glycerol phosphate. Total cholesterol (TC) was
measured using the enzymatic colorimetric method with
cholesterol esterase and cholesterol oxidase. High-density
lipoprotein cholesterol (HDL-C) was assayed based on mod-
ified Friedewald to calculate LDL-C. All metabolic analyses
were performed using (Pars Azmon Inc., Tehran, Iran) and a
Selecta 2 autoanalyzer (Vital Scientific, Spankeren, Nether-
lands) kits. Intra/inter-assay coefficients of variations for
TG, TC, HDL-C, and LDL-C were less than 2.1, 1.9, 3, and 3%, re-
spectively. Serum creatinine (cr) concentrations were mea-
sured by kinetic colorimetric Jaffe; sensitivity of the assay
was 0.2 mg/dL (range: 18 - 1330 µmol/L (0.2 - 15 mg/dL).
Intra/inter-assay CVs were less than 3.1%. All biochemical as-
says were performed using commercial kits (Pars Azmoon
Inc., Tehran, Iran) using a Selectra 2 autoanalyzer (Vital Sci-
entific, Spankeren, The Netherlands). Assay performance
was monitored after every 25 tests using lyophilized serum
controls in normal and pathologic ranges. All samples
were analyzed only when the internal quality control met
the standard acceptable criteria.
3.3. Definition of Terms
Infertility was defined as the inability of a ‘couple’ to
get pregnant despite 12 or more months of unprotected
sexual intercourse (20), and male infertility was defined
as any infertility that attributed to male factor diagnosed
by sperm parameters below the normal values recom-
mended by the world health organization (21). In the
present study, information about male infertility were ob-
tained by investigating the history of infertility, using a
self-reported questionnaire, and were further confirmed
by medical documentation. Hypertension was defined (22)
as a mean systolic blood pressure ≥ 140 mmHg, mean di-
astolic blood pressure ≥ 90 mmHg, or undergoing treat-
ment for hypertension. Metabolic syndrome was defined
(23) as having at least three of the following five criteria: TG
concentration of≥ 150 mg/dL or receiving specific medica-
tion; HDL≤40 mg/dL or receiving specific medication; SBP
≥ 130 mmHg, or DBP ≥ 85 mm Hg, or receiving specific
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medication; FPG ≥ 100 mg/dL or receiving specific treat-
ment; and waist circumference ≥ 90 cm for men accord-
ing to the Iranian population-specific threshold. Dyslipi-
demia was defined as a TG level≥ 240 mg/dL, or LDL≥ 160
mg/dL, or TG ≥ 200 mg/dL, or HDL < 40 mg/dL, or receiv-
ing specific medication (24). Obesity was defined as BMI
≥ 30 kg/m2, and central obesity was defined as a WC ≥ 90
cm (25). Chronic kidney disease (CKD) was defined as an es-
timated glomerular filtration rate (GFR) < 60 mL/min/1.73
m2 (26). In this study, GFR was calculated using the ab-
breviated prediction equation, provided by the modifica-
tion of diet in renal disease (MDRD) study as follows: GFR =
186 × (SCr) -1.154 × (Age) -0.203, in which eGFR (estimated
GFR) is presented as mL/min per 1.73 m2, and serum crea-
tinine (Scr) is presented as mg/dL. Diabetes was defined as
FPG ≥126 mg/dL or 2-hpost-challenge plasma glucose (2 h-
PCPG)≥ 200 mmol/L or taking anti-diabetic medication in
all phases of the study (27).
3.4. Statistical Analyses
Based on the primary outcome of hypertension, which
refers to the probability of detecting a difference between
study groups when a true difference exists (prevalence of
HTN in the infertile and fertile group: 39 and 26%, k: group
ratio 1523/88 ≈ 17 and type one error: 5%), the statistical
power was estimated at 70%. The Kolmogorov-Smirnov test
was applied to test for a normal distribution. Baseline char-
acteristics of both groups were compared using the Mann-
Whitney U, t-student, and chi-squared tests. Logistic regres-
sion was performed to investigate the association between
cardiometabolic disturbances and male infertility. In ad-
dition, odds ratios with a 95% confidence interval were es-
timated to show the association. Moreover, penalized lo-
gistic regression via the data augmentation method was
used to avoid potential biases. Statistical analyses were
performed using STATA version 14 (STATA Inc., College Sta-
tion, TX, USA), and the Penlogit STATA package was applied
to run the data augmentation method. Statistical signifi-
cance was considered when P-value < 0.05.
4. Results
Baseline characteristics of participants are presented
in Table 1. Compared to fertile controls, infertile men were
more likely to be older, [58 (13.3) versus 53 (10.2) years (P =
0.003)], respectively, and had significantly higher SBP [120
(28.8) vs. 115 (18) mm Hg, P < 0.001], FBS [93 (10.3) vs. 91 (11)
mg/dL, respectively; P = 0.011] and Bs-2hPG [115.5 (46) vs. 104
(45) mg/dL, respectively; P < 0.0014].
The crude age and BMI adjusted associations between
cardio-metabolic disorders and male fertility status are
provided in Table 2. The unadjusted model revealed a sig-
nificant association between infertility and hypertension
and CKD (OR = 1.8; 95% CI: 1.2, 2.9; P = 0.006, and OR = 1.9;
95% CI: 1.1, 3.6; P = 0.033, respectively). However, the sig-
nificant association found in the crude analysis was dis-
appeared after adjusting for potential confounders of age
and BMI. Moreover, infertility did not have any associa-
tion with other cardiometabolic disturbances, including
diabetes and pre-diabetes, metabolic syndrome, dyslipi-
demia, obesity, and central obesity in both unadjusted and
adjusted analyses.
5. Discussion
In the present study, following a population-based
cross-sectional design, we found no association between
the history of male infertility and cardio-metabolic distur-
bances in infertile men compared to their healthy fertile
counterparts. Male infertility is a multi-dimensional prob-
lem that is expected to grow during the next two decades
(28). Emerging evidence suggests an intertwined link be-
tween male infertility and their overall health status (6,
29). However, in the last two decades, several studies have
investigated the prevalence and incidence of some cardio-
metabolic comorbidities in populations of patients with
male infertility. In contrast to our findings, most data from
these series supported the association between infertility
and those disturbances (6, 30-33). In this respect, Lawlor et
al. (2003) assessed the association between the prevalence
of coronary heart diseases (CHD) and the number of off-
spring in a sample of the British population. They showed
that men with ≤ 1 child had a higher risk of CHD com-
pared to those with more children (34). In the same vein,
Ringbäck Weitoft analyzed cause-specific mortality data of
682919 lone fathers and childless men living in Sweden and
reported an enhanced risk of ischemic heart disease (35).
Likewise, Eisenberg et al. investigated the association be-
tween semen secretion and medical comorbidity in a co-
hort of 9387 men with available semen analysis in a fertil-
ity clinic. They reported a significant association between
cardiovascular disease (i.e., hypertension, peripheral vas-
cular diseases, cerebrovascular diseases, and non-ischemic
heart diseases) and a significantly higher rate of any type
of semen abnormality (30). In another recently published
study, Helene Glazer et al., in a Danish national IVF register-
based cohort study on 39516 men with a history of fertility
treatment, reported that male infertility may contribute
to the development of diabetes mellitus. However, those
risks were related to the severity of the underlying fertil-
ity factors (36). The results of our population-based study
are not in line with the literature, which supports the asso-
ciation between cardio-metabolic disturbances and male
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Table 1. Baseline Characteristics of the Study Population According to Their History of Male Infertility
Variables Infertile (n = 88) Fertile (n = 1523) P-Value
Age, (y) a 58 ± 13 53 ± 10 0.003 b
BMI, (kg/m2) a 26 ± 4 26 ± 4 0.513
WHR 0.93 ± 0.08 0.93 ± 0.08 0.789
SBP, (mmHg) c 120 (106, 134) 115 (106, 124) 0.001 b
DBP, (mmHg) c 78 (71, 85) 78 (71, 85) 0.155
TC (mg/dL) c 181 (141, 211) 191 (167, 215) 0.307
TG (mg/dL) c 158 (107, 204) 161 (107, 216) 0.841
HDL-C (mg/dL) c 41 (36, 47) 42 (36, 48) 0.883
LDL-C (mg/dL) a 116 ± 32 117 ± 32 0.640
FBS (mg/dL) c 93 (88, 98) 91 (85, 97) 0.011 b
Bs-2hPG (mg/dL) c 116 (93, 139) 104 (81, 127) 0.014 b
Educational level, yes (%) 0.584
Academic 9 (15) 171 (14)
Non-academic 53 (86) 1037 (86)
Smoking history, yes (%) 18 (20) 257 (21) 0.539
Abbreviations: BMI, body mass index; WHR, waist to hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL-C,
high-density lipoprotein; LDL-C, low-density lipoprotein cholesterol; FBS, fasting plasma glucose; Bs-2hPG, 2-hour plasma glucose.
a Values are expressed as mean ± SD.
b Values are statistically significant.
c Values are expressed as median (Q1, Q3).
Table 2. Association of Cardiometabolic Disorders with Male Infertility Status a
Outcomes Infertile (n = 88) fertile (n = 1523) Unadjusted OR (95% CI) Age-BMI adjusted OR (95% CI)
Diabetes mellitus 21 (32) 300 (25) 1.3 (0.8, 2.3) 1.1 (0.6, 2.0)
Pre-diabetes 26 (30) 368 (24) 1.3 (0.8, 2.1) 1.1 (0.7, 1.8)
Hypertension 34 (39) 389 (26) 1.8 (1.2, 2.9) b 1.4 (0.8, 2.3)
Metabolic syndrome 48 (55) 731 (48) 1.3 (0.8, 2.0) 1.1 (0.7, 1.9)
Dyslipidemia 47 (53) 822 (54) 0.9 (0.6, 1.5) 1.0 (0.6, 1.7)
Obesity 23 (26) 366 (24) 1.1 (0.7, 1.9) 1.5 (0.4, 5.7)
Central Obesity 32 (36) 503 (33) 1.1 (0.7, 1.9) 1.1 (0.6, 2.1)
CKD 13 (15) 125 (8) 1.9 (1.1, 3.6) b 1.3 (0.6, 3.5)
a Values are expressed as No. (%) unless otherwise indicated.
b Value is statistically significant (P-value < 0.05).
infertility. These disparate findings can be attributed to
differences in methodologies applied to measure fertility.
Unlike female infertility, treating male infertility is a chal-
lenging issue and is not well investigated in general (1),
which may potentially lead to conflicting results. In this
respect, male infertility has not been defined as an inde-
pendent disease (1). In the lack of a unique definition, most
studies have used various criteria like infertility-associated
disorders or the childless situation of men. However, al-
though those may contribute to male infertility, but do not
necessarily imply male infertility; thus, limiting the inter-
pretability of the data. Moreover, most studies on male in-
fertility did not have a population-based design and were
performed in the tertiary settings, mainly infertility clin-
ics, which potentially include severe forms of infertility
that are not a representative sample of the larger popu-
lation of infertile men, which may indicate an important
bias. In addition, in some contexts, men disclaim infertil-
ity help-seeking traditionally and do not usually agree to
undergo fertility evaluation, resulting in underestimating
male infertility. However, different populations vary by age
range, ethnicity, and unit of measurement, as well as other
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risk factors, which probably have affected the results.
It is necessary to mention some limitations and biases
of our study, including only evaluating Iranian men, which
limited the generalizability of the findings to other con-
texts.
Furthermore, infertility diagnosis was self-reported,
which may be limited by recall bias. However, the di-
agnoses were further confirmed by reviewing the medi-
cal records of participants. In addition, previous studies
found a negligible association between self-reported and
confirmed infertility (37, 38). Moreover, since the infertility
data were collected in the third phase of the TLGS, we could
not perform a longitudinal study to assess the risk of car-
diometabolic events in infertile men due to insufficiency
of infertile individuals and short-term follow-up. However,
since TLGS is an ongoing study, it will let us perform such
analyses with a longitudinal design in the future.
However, since a cross-sectional design was followed,
we did not identify the causality between infertility and
cardiometabolic disturbances. Long-term prospective
studies are needed to investigate those causality effects.
5.1. Conclusions
In conclusion, our study demonstrated no associa-
tion between male infertility and cardiometabolic distur-
bances. By focusing solely on men in a population-based
setting, we tried to fill the gaps in knowledge in the infer-
tile male population. The findings can pave the way for fur-
ther studies to extend our knowledge in this field. More
population-based studies with a large sample size are war-
ranted to confirm these findings.
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